{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:35Z","timestamp":1790627975197,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clindermatol.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:33:44Z","timestamp":1585769624000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["RASopathies"],"prefix":"10.1016","volume":"38","author":[{"given":"Mustufa","family":"Jafry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.03.010_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/349117a0","article-title":"The GTPase superfamily: conserved structure and molecular mechanism","volume":"349","author":"Bourne","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0010","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.0705218104","article-title":"Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern","volume":"104","author":"Hafner","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0015","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","article-title":"Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi","volume":"116","author":"Hafner","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","article-title":"Noonan syndrome and related disorders: genetics and pathogenesis","volume":"6","author":"Tartaglia","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000276766","article-title":"Noonan syndrome: clinical aspects and molecular pathogenesis","volume":"1","author":"Tartaglia","year":"2010","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajmg.1320310208","article-title":"Bleeding diathesis in Noonan syndrome: a common association","volume":"31","author":"Witt","year":"1988","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archderm.1978.01640180063015","article-title":"Cutaneous manifestations of Noonan\u2019s syndrome","volume":"114","author":"Wyre","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0050","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ejhg.2015.175","article-title":"The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome","volume":"24","author":"Joyce","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0055","first-page":"315","article-title":"Is neurofibromatosis type 1-Noonan syndrome a phenotypic result of combined genetic and epigenetic factors?","volume":"30","author":"Yapijakis","year":"2016","journal-title":"In Vivo"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D329S5592H","article-title":"Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway","volume":"17","author":"Reig","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-57379-3_14","article-title":"Neurofibromatosis-Noonan syndrome: a possible paradigm of the combination of genetic and epigenetic factors","volume":"987","author":"Yapijakis","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0070","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/498454","article-title":"NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome","volume":"77","author":"De Luca","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajmg.a.31156","article-title":"LEOPARD syndrome: clinical diagnosis in the first year of life","volume":"140","author":"Digilio","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2003.013466","article-title":"Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome","volume":"41","author":"Sarkozy","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gim.0b013e31822dd91f","article-title":"Costello syndrome: a Ras\/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations","volume":"14","author":"Gripp","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.4.e37","article-title":"Studies on the pathogenesis of Costello syndrome","volume":"40","author":"Mancini","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: an overview","volume":"117C","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0110","series-title":"Costello Syndrome - NORD (National Organization for Rare Disorders)","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jmg.2006.042796","article-title":"The cardiofaciocutaneous syndrome","volume":"43","author":"Roberts","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0120","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1542\/peds.2013-3189","article-title":"Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines","volume":"134","author":"Pierpont","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jmg.36.10.799","article-title":"Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome","volume":"36","author":"van Den Berg","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes","volume":"157C","author":"Kratz","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0135","series-title":"Cardiofaciocutaneous Syndrome","author":"Rauen","year":"2012"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-62702-5.00004-4","article-title":"Neurofibromatosis type 1","volume":"132","author":"Anderson","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0160","series-title":"Legius syndrome","author":"Stevenson","year":"2015"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0165","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/humu.22152","article-title":"Review and update of SPRED1 mutations causing Legius syndrome","volume":"33","author":"Brems","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0170","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/0883073809359540","article-title":"SPRED 1 mutations in a neurofibromatosis clinic","volume":"25","author":"Muram-Zborovski","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0175","doi-asserted-by":"crossref","first-page":"E1985","DOI":"10.1002\/humu.21404","article-title":"Legius syndrome in fourteen families","volume":"32","author":"Denayer","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0180","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/jid.2014.244","article-title":"Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies","volume":"134","author":"Luo","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0185","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bjd.16435","article-title":"Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma","volume":"179","author":"Prieto-Barrios","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/bjd.17102","article-title":"What do mosaic RASopathies tell us about carcinogenesis?","volume":"179","author":"Siegel","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.sder.2008.03.006","article-title":"Epidermal nevus syndromes","volume":"26","author":"Sugarman","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0200","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1056\/NEJMc1109381","article-title":"HRAS mutation mosaicism causing urothelial cancer and epidermal nevus","volume":"365","author":"Hafner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0205","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2133.2012.10812.x","article-title":"Identification of a novel S249C FGFR3 mutation in a keratinocytic epidermal naevus syndrome","volume":"167","author":"Ousager","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmg.2009.075374","article-title":"Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma","volume":"47","author":"Bourdeaut","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0215","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/0972-2327.144042","article-title":"Linear nevus sebaceous syndrome","volume":"17","author":"Pauline","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0220","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.scs.0000221531.56529.cc","article-title":"Nevus sebaceus of Jadassohn","volume":"17","author":"Terenzi","year":"2006","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000460258","article-title":"Dermoscopic analysis of nevus sebaceus of Jadassohn: a study of 13 cases","volume":"3","author":"Kelati","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0230","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.5021\/ad.2011.23.S2.S231","article-title":"Nevus sebaceous accompanying secondary neoplasms and unique histopathologic findings","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pediatrneurol.2007.10.012","article-title":"Linear nevus sebaceous syndrome: case reports and review of the literature","volume":"38","author":"Menascu","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s10038-018-0539-3","article-title":"A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus","volume":"64","author":"Nagatsuma","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0250","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cge.12775","article-title":"Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis","volume":"90","author":"Boppudi","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0255","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MPH.0000000000001170","article-title":"Encephalocraniocutaneous Lipomatosis","volume":"40","author":"Bavle","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0260","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0265","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0270","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gde.2005.03.004","article-title":"RASA1: variable phenotype with capillary and arteriovenous malformations","volume":"15","author":"Boon","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0275","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ijd.12040","article-title":"Capillary malformation-arteriovenous malformation: a clinical review of 45 patients","volume":"53","author":"Larralde","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0280","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000331266","article-title":"RASopathies: clinical diagnosis in the first year of life","volume":"1","author":"Digilio","year":"2011","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0285","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0290","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41598-018-20894-0","article-title":"Integrating functional analysis in the next-generation sequencing diagnostic pipeline of RASopathies","volume":"8","author":"Leung","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0295","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/gim.2016.169","article-title":"Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing","volume":"19","author":"Bhoj","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0300","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.1324128111","article-title":"Next-generation sequencing identifies rare variants associated with Noonan syndrome","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0310","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2011.06.016","article-title":"Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study","volume":"45","author":"Acosta","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.010_bb0315","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.c.30294","article-title":"Costello and cardio-facio-cutaneous syndromes: moving toward clinical trials in RASopathies","volume":"157C","author":"Rauen","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2030047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2030047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:50Z","timestamp":1760033810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X2030047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0738081X2030047X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RASopathies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}